NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
72888-001-15 | 72888-001 | HUMAN PRESCRIPTION DRUG | tizanidine hydrochloride | tizanidine hydrochloride | CAPSULE | ORAL | 20200527 | N/A | ANDA | ANDA213798 | Advagen Pharma Limited | TIZANIDINE HYDROCHLORIDE | 2 mg/1 | 150 CAPSULE in 1 BOTTLE (72888-001-15) |
72888-003-15 | 72888-003 | HUMAN PRESCRIPTION DRUG | tizanidine hydrochloride | tizanidine hydrochloride | CAPSULE | ORAL | 20200527 | N/A | ANDA | ANDA213798 | Advagen Pharma Limited | TIZANIDINE HYDROCHLORIDE | 6 mg/1 | 150 CAPSULE in 1 BOTTLE (72888-003-15) |
72888-002-15 | 72888-002 | HUMAN PRESCRIPTION DRUG | tizanidine hydrochloride | tizanidine hydrochloride | CAPSULE | ORAL | 20200527 | N/A | ANDA | ANDA213798 | Advagen Pharma Limited | TIZANIDINE HYDROCHLORIDE | 4 mg/1 | 150 CAPSULE in 1 BOTTLE (72888-002-15) |